Investor Presentation
•
•
Introduction to 4DMedical
•
•
•
Founded in 2012, 4DMedical Limited is a Melbourne-based software
technology company focused on creating a step change in the
capacity of physicians to diagnose and manage patients with
diseases of the lung
The respiratory diagnostic sector represents a global market of over
US$31 billion per annum, with over 377 million respiratory
diagnostics tests performed each year
4DMedical is focused on commercialising its four-dimensional XV lung
imaging technology, which utilises proven, patented algorithms to
convert X-ray images into quantitative scan data
Unlike existing respiratory diagnostic procedures, 4DMedical's
proprietary XV technology provides a non-invasive way of
understanding regional lung motion and airflow in real-time
With FDA clearance in place, 4DMedical's major focus is on US
market commercialisation of its XV Technology
Australian TGA approval for XV Lung Ventilation Analysis Software
(LVAS) allows 4DMedical to gain local traction quickly through
leveraging existing industry knowledge and relationships
The SaaS business model offers hospitals access to the technology
without the traditional issues of hardware integration, capex,
additional staff or re-training
4DMedical's advancement in respiratory diagnostic technology is
expected to result in improved patient experiences, earlier
intervention leading to improved healthcare outcomes, with
reduced costs of care
>
Pg 3 Investor presentation
Vereni
4DMedical
4DMedicalView entire presentation